{"id":"W4386268787","doi":"10.1093/oncolo/oyad223","title":"Adjuvant Systemic Therapies for Resected Stages III and IV Melanoma: A Multi-Center Retrospective Clinical Study","year":2023,"lang":"en","type":"article","venue":"The Oncologist","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; University of Calgary; Alberta Health Services","funders":"OPKO Health; Clovis Oncology; Novavax; Karyopharm Therapeutics; INOVIO Pharmaceuticals; Sanofi; Abeona Therapeutics; Acorda Therapeutics; Pfizer","keywords":"Medicine; Melanoma; Adjuvant; Internal medicine; Adjuvant therapy; Systemic therapy; Oncology; Adverse effect; Immunotherapy; Clinical trial; Single Center; Progression-free survival; Retrospective cohort study; Stage (stratigraphy); Surgery; Cancer; Overall survival","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001275863,0.0001473185,0.0004426498,0.000088432,0.0002256509,0.0000344525,0.0001175419,0.00007988221,0.0000252768],"category_scores_gemma":[0.0003624846,0.00008661037,0.00008995423,0.0002280495,0.0001989746,0.00002528606,0.0001383072,0.0002153127,0.0000375767],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001404147,"about_ca_system_score_gemma":0.00003994737,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000110382,"about_ca_topic_score_gemma":0.0005415815,"domain_scores_codex":[0.998626,0.0002235869,0.0003744593,0.0003502381,0.0001812665,0.0002444788],"domain_scores_gemma":[0.9989461,0.0003785706,0.0001336096,0.0003596762,0.000110865,0.00007112861],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01217917,0.007185833,0.8666027,0.0004153461,0.003299622,0.001513335,0.01741686,0.000009907051,0.003465155,0.0008986999,0.05252445,0.03448888],"study_design_scores_gemma":[0.02577502,0.0117459,0.8989204,0.0001029385,0.0004653898,0.000327811,0.04112543,0.001288821,0.00004089297,0.0000835906,0.01985983,0.0002640512],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929925,0.0002145515,0.0001541539,0.001770169,0.0006365046,0.003300386,0.00002657651,0.0003278171,0.0005773254],"genre_scores_gemma":[0.9890717,0.0003249085,0.00008317708,0.0002437608,0.0002359755,0.0003171165,0.00001223129,0.00002344808,0.009687721],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03422483,"threshold_uncertainty_score":0.3531868,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08479655175958822,"score_gpt":0.3904699091171679,"score_spread":0.3056733573575797,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}